Investigation of treatment-guiding gene signatures in cancer using RNA-sequencing data
Cancer is the leading cause of death in the world. Multiple different treatment options are available, target therapy and immunotherapy being two. One potential target is Fibroblast Growth Factor Receptors (FGFRs) and there are both available treatments and new treatments being investigated for this. However, only around 25% of patients benefit from the immunotherapy treatment Immune Checkpoint In
